Heron Therapeutics, Inc. /De/ financial data

Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4242 Campus Point Court, Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
AP PHARMA INC /DE/ (to 1/7/2014), ADVANCED POLYMER SYSTEMS INC /DE/ (to 4/6/2001)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 241 % +6.37%
Quick Ratio 53.8 % -9.93%
Debt-to-equity -765 % +88.3%
Return On Equity 144 % -96.1%
Return On Assets -21.7 % +62.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152M shares +7.75%
Common Stock, Shares, Outstanding 150M shares +26.1%
Entity Public Float 120M USD -58.1%
Common Stock, Value, Issued 1.52M USD +26.4%
Weighted Average Number of Shares Outstanding, Basic 152M shares +27.2%
Weighted Average Number of Shares Outstanding, Diluted 152M shares +27.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 42.9M USD -26.9%
Selling and Marketing Expense 50.3M USD -35.9%
General and Administrative Expense 42.5M USD -21.6%
Costs and Expenses 136M USD -17.1%
Operating Income (Loss) -46.4M USD +66.3%
Net Income (Loss) Attributable to Parent -48.1M USD +64.8%
Earnings Per Share, Basic -0.26 USD/shares +76.6%
Earnings Per Share, Diluted -0.26 USD/shares +76.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.4M USD +36.6%
Cash, Cash Equivalents, and Short-term Investments 67.3M USD +103%
Accounts Receivable, after Allowance for Credit Loss, Current 73.7M USD -3.89%
Inventory, Net 42.9M USD -3.94%
Assets, Current 191M USD +15.7%
Property, Plant and Equipment, Net 15.9M USD -23.8%
Operating Lease, Right-of-Use Asset 4.14M USD -36.2%
Other Assets, Noncurrent 6.93M USD -19.3%
Assets 218M USD +8.41%
Accounts Payable, Current 10.2M USD +423%
Employee-related Liabilities, Current 7.09M USD -28.1%
Liabilities, Current 80.3M USD -7.39%
Operating Lease, Liability, Noncurrent 1.29M USD -69%
Other Liabilities, Noncurrent 241K USD 0%
Liabilities 256M USD +6.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8K USD -33.3%
Retained Earnings (Accumulated Deficit) -1.92B USD -2.57%
Stockholders' Equity Attributable to Parent -37.9M USD +3.42%
Liabilities and Equity 218M USD +8.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.52M USD +61.8%
Net Cash Provided by (Used in) Financing Activities -208K USD +67.3%
Net Cash Provided by (Used in) Investing Activities 1.28M USD -96.5%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 150M shares +26.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.23M USD -170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.4M USD +36.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 649K USD
Deferred Tax Assets, Valuation Allowance 430M USD +1.65%
Deferred Tax Assets, Gross 431M USD +1.51%
Operating Lease, Liability 4.48M USD -33.5%
Payments to Acquire Property, Plant, and Equipment 224K USD -78.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.1M USD +64.8%
Lessee, Operating Lease, Liability, to be Paid 4.72M USD -36%
Property, Plant and Equipment, Gross 37.2M USD +2.03%
Operating Lease, Liability, Current 3.19M USD +23.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14M USD +3.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.14M USD +3.56%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 233K USD -63.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.1M USD -27.5%
Deferred Tax Assets, Operating Loss Carryforwards 321M USD +2.28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2.5M shares 0%
Unrecognized Tax Benefits 10.9M USD -2.96%
Additional Paid in Capital 1.88B USD +2.69%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 689K USD -4.04%
Share-based Payment Arrangement, Expense 19M USD -56.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%